35 Stocks Moving In Tuesday's Mid-Day Session



  • Cerevel Therapeutics Holdings, Inc. CERE shares jumped 111.5% to $26.58 after the company announced positive results from its Phase 1b clinical trial of CVL-231 in adult patients with schizophrenia. CVL-231 was generally well-tolerated, and discontinuation rates were similar between CVL-231 and placebo in the six weeks of dosing, at 22% each.
  • BSQUARE Corporation BSQR climbed 82.4% to $4.78 after gaining over 8%on Monday.
  • Marin Software Incorporated MRIN jumped 59.4% to $11.95 after jumping around 97% on Monday. Marin Software, last week, announced it has added the ability to manage Instacart Ads to its flagship MarinOne platform.
  • Exela Technologies, Inc. XELA jumped 45% to $2.13 after gaining over 5% on Monday.
  • Auddia Inc. AUUD shares jumped 40.7% to $8.29 after the company announced the release and national launch of its flagship Auddia app ahead of schedule.
  • Bridgeline Digital, Inc. BLIN gained 24% to $3.07.
  • Baosheng Media Group Holdings Limited BAOS gained 20.6% to $4.0883.
  • Infobird Co., Ltd IFBD surged 18.7% to $4.6066.
  • Amesite Inc. AMST rose 18% to $3.03.
  • Graphite Bio, Inc. GRPH gained 14.2% to $25.93. The company recently priced its IPO at $17 a share.
  • Smart Sand, Inc. SND gained 13.7% to $3.47. Smart Sand entered into a $35 million settlement with US Well Services, LLC. Evercore ISI Group upgraded Smart Sand from Underperform to In-Line and announced a $4 price target.
  • Translate Bio, Inc. TBIO gained 13.1% to $25.79. Sanofi and Translate Bio recently said they have initiated a Phase 1 clinical trial evaluating an mRNA-based investigational vaccine against seasonal influenza.
  • Digital Brands Group, Inc. DBGI surged 12.2% to $6.16. Digital Brands, on Monday, reported first-quarter FY21 revenue of $408 thousand, down 84% year-on-year.
  • Diginex Limited EQOS gained 11.3% to $7.09.
  • LMP Automotive Holdings, Inc. LMPX jumped 10.8% to $18.29 ahead of quarterly earnings.
  • PLBY Group, Inc. PLBY rose 9.4% to $41.48 after the company announced it will acquire Birdette for $333 million in cash and stock.
  • Jefferies Financial Group Inc. JEF shares surged 8.6% to $34.71 after the company reported strong Q2 results and raised its quarterly dividend.
  • Universe Pharmaceuticals INC UPC shares gained 6.8% to $3.1601 after declining 4% on Monday. Universe Pharmaceuticals, last month, entered into Letter of Intent for strategic cooperation with Kitanihon Pharmaceutical.
  • Morgan Stanley MS shares rose 4.3% to $91.47 after the company announced it raised its quarterly dividend from $0.35 to $0.70 per share and announced a $12 billion buyback.

Check out these big penny stock gainers and losers


  • Better Choice Company Inc BTTR shares fell 34% to $4.87 after the company reported the pricing of its underwritten public offering of 8,000,000 shares at $5.00 per share.
  • DiaMedica Therapeutics Inc. DMAC fell 33.2% to $4.79 after the company announced positive interim results from its Phase 2 REDUX trial of DM199 in chronic kidney disease. DM199, the company noted, is demonstrating clinically meaningful improvements in kidney function in Cohorts 1 and 2, as measured by a simultaneously stabilizing estimated glomerular filtration rate and decreasing urine albumin-to-creatinine ratio.
  • MediWound Ltd. MDWD fell 29.4% to $3.9801. Vericel’s development partner, MediWound, received a complete response letter from FDA regarding the NexoBrid application seeking approval for eschar removal in adults with deep partial-thickness or full-thickness burns.
  • ReShape Lifesciences Inc. RSLS dipped 23.8% to $5.82 after the company entered into a warrant exercise transaction for $46.2 million in gross proceeds.
  • Celcuity Inc. CELC shares fell 18.7% to $25.15 after the company priced its underwritten public offering of 2,250,000 shares at $25.00 per share.
  • X Financial XYF dipped 15.9% to $13.85 after gaining over 9% on Monday.
  • Sensei Biotherapeutics, Inc. SNSE fell 14.8% to $9.24 after the company said it is reprioritizing its pipeline programs to focus on its product candidates, including its multi-antigenic next generation ImmunoPhage candidate, now referred to as SNS-401-NG, and its monoclonal antibody SNS-VISTA candidate. Oppenheimer downgraded Sensei Biotherapeutics from Outperform to Perform.
  • Aligos Therapeutics, Inc. ALGS fell 13.2% to $20.61 after the company announced a proposed public offering of 4 million shares of common stock.
  • Alfi, Inc. ALF dropped 12.6% to $16.25.
  • Anavex Life Sciences Corp. AVXL dipped 11.3% to $25.61. Anavex Life Sciences recently announced ANAVEX2-73 improved both primary cognitive and secondary MDS-UPDRS efficacy endpoints with significant biomarker correlation in placebo-controlled Phase 2 clinical trial for treatment of Parkinson's.
  • Virgin Galactic Holdings, Inc. SPCE fell 10.9% to $48.85 as the stock pulled back after spiking last week following FAA approval for its passenger flight license.
  • Kiromic BioPharma, Inc. KRBP fell 10.4% to $7.16 after dropping 20% on Monday.
  • LexinFintech Holdings Ltd. LX dipped 10.1% to $11.90. The company last week announced a partnership with Huawei.
  • Zosano Pharma Corporation ZSAN shares fell 7.7% to $0.9320. Zosano Pharma’s filing showed registration for $30 million common stock offering.
  • Graybug Vision, Inc. GRAY shares fell 7.1% to $5.67 after climbing 17% on Monday.
  • Herman Miller, Inc. MLHR dropped 6.5% to $44.83. Herman Miller reported better-than-expected results for its fourth quarter. However, the company issued weak earnings forecast for the current quarter.
Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasMid-Day MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!